重组人C1酯酶抑制剂用于孕期遗传性血管性水肿发作的安全性。 - Suppr

Suppr

超能文献

Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy.

作者信息

Moldovan Dumitru, Bernstein Jonathan A, Hakl Roman, Porebski Grzegorz, Poarch Kimberly, Lumry William R, Relan Anurag

机构信息

MediQuest Clinical Research, Sangeorgiu de Mures, Romania.

University of Cincinnati, College of Medicine, Cincinnati, Ohio.

出版信息

J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2938-2940. doi: 10.1016/j.jaip.2019.05.042. Epub 2019 Jun 3.

DOI:10.1016/j.jaip.2019.05.042

PMID:31170541

Abstract

摘要

相似文献

Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy.重组人C1酯酶抑制剂用于孕期遗传性血管性水肿发作的安全性。

J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2938-2940. doi: 10.1016/j.jaip.2019.05.042. Epub 2019 Jun 3.

A recombinant C1 esterase inhibitor (Ruconest) for hereditary angioedema.一种用于遗传性血管性水肿的重组C1酯酶抑制剂（Ruconest）。

Med Lett Drugs Ther. 2016 Mar 28;58(1491):e44-5.

Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.重组 C1 抑制剂治疗遗传性血管性水肿发作的疗效和安全性：一项北美开放性研究。

Ann Allergy Asthma Immunol. 2013 Apr;110(4):295-9. doi: 10.1016/j.anai.2013.02.007. Epub 2013 Mar 6.

Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.妊娠期采用艾替班特和重组 C1 抑制剂治疗遗传性血管性水肿发作。

J Clin Immunol. 2018 Oct;38(7):810-815. doi: 10.1007/s10875-018-0553-4. Epub 2018 Oct 2.

Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.人C1酯酶抑制剂浓缩物与安慰剂相比在急性遗传性血管性水肿发作中的疗效。

J Allergy Clin Immunol. 2009 Oct;124(4):801-8. doi: 10.1016/j.jaci.2009.07.017. Epub 2009 Sep 19.

Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial.重组人 C1 酯酶抑制剂预防遗传性血管性水肿：一项 2 期、多中心、随机、双盲、安慰剂对照交叉试验。

Lancet. 2017 Sep 30;390(10102):1595-1602. doi: 10.1016/S0140-6736(17)31963-3. Epub 2017 Jul 25.

Hereditary angioedema and pregnancy: a successful outcome using C1 esterase inhibitor concentrate.遗传性血管性水肿与妊娠：使用C1酯酶抑制剂浓缩物的成功案例

Can Fam Physician. 2008 Mar;54(3):365-6.

Recombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiency.C1抑制剂缺乏所致遗传性血管性水肿的重组替代疗法。

Immunotherapy. 2015;7(7):739-52. doi: 10.2217/imt.15.44. Epub 2015 Aug 7.

Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.重组人 C1 抑制剂治疗遗传性血管性水肿患者的急性血管性水肿发作。

J Allergy Clin Immunol. 2010 Oct;126(4):821-827.e14. doi: 10.1016/j.jaci.2010.07.021.

Acute Management of Hereditary Angioedema Attacks.遗传性血管性水肿发作的急性处理

Immunol Allergy Clin North Am. 2017 Aug;37(3):541-556. doi: 10.1016/j.iac.2017.04.002. Epub 2017 May 23.

引用本文的文献

Current challenges and future opportunities in patient-focused management of hereditary angioedema: A narrative review.遗传性血管性水肿以患者为中心管理中的当前挑战与未来机遇：一项叙述性综述

Clin Transl Allergy. 2023 May;13(5):e12243. doi: 10.1002/clt2.12243.

Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age.育龄期女性因C1-INH缺乏所致遗传性血管性水肿的管理考量

Allergy Asthma Clin Immunol. 2022 Jul 13;18(1):64. doi: 10.1186/s13223-022-00689-9.

The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.国际血管性水肿学会（WAO）/欧洲变态反应和临床免疫学会（EAACI）遗传性血管性水肿管理指南——2021年修订与更新

World Allergy Organ J. 2022 Apr 7;15(3):100627. doi: 10.1016/j.waojou.2022.100627. eCollection 2022 Mar.

Hereditary Angioedema Attack in Utero and Treatment of the Mother and Fetus.子宫内遗传性血管性水肿发作及母婴治疗

Mayo Clin Proc Innov Qual Outcomes. 2020 Aug 22;4(5):595-600. doi: 10.1016/j.mayocpiqo.2020.06.004. eCollection 2020 Oct.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验